SCHEMBL846639

SCHEMBL846639

O=C(Nc1ccc2cc(F)ccc2n1)c1ccc(N2CCCCCCC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.59
NPC1 O15118 9/20 0.59
SMN1; SMN2 Q16637 6/20 0.59
TP53 P04637 4/20 0.59
MAPK1 P28482 3/20 0.59
ALOX15 P16050 1/20 0.59
HTT P42858 1/20 0.59
ALDH1A1 P00352 2/20 0.53
LRRK2 Q5S007 1/20 0.52
MAPT P10636 8/20 0.50
TSHR P16473 2/20 0.50
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
KDM4E B2RXH2 2/20 0.48
HPGD P15428 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
HTR2C P28335 1/20 0.48
MCHR1 Q99705 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL846076 0.81 RAB9A (0.65) RAB9ANPC1SMN1; SMN2TP53MAPK1
SCHEMBL846721 0.81 RAB9A (0.65) RAB9ANPC1SMN1; SMN2TP53MAPK1
SCHEMBL847375 0.76 TRPV1 (0.58) RAB9ANPC1MAPTKMT2AMEN1
SCHEMBL19392500 0.76 NPC1 (0.67) RAB9ANPC1SMN1; SMN2TP53MAPK1
SCHEMBL847374 0.75 NAMPT (0.45) RAB9ANPC1HTR2CMCHR1POLB
SCHEMBL18470910 0.75 RAB9A (1.00) RAB9ANPC1SMN1; SMN2TP53MAPK1
SCHEMBL3142490 0.75 RAB9A (1.00) RAB9ANPC1SMN1; SMN2TP53MAPK1
SCHEMBL846391 0.72 SMN1; SMN2 (0.55) RAB9ANPC1SMN1; SMN2TP53MAPK1
SCHEMBL846284 0.71 RAB9A (0.57) RAB9ANPC1SMN1; SMN2TP53MAPK1
SCHEMBL846074 0.71 KDR (0.67) RAB9ANPC1SMN1; SMN2TP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP claimed